MAUDE Adverse Event Report: SMITH & NEPHEW ORTHOPAEDICS LTD RESURFACING FEMORAL HEAD 50MM; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING

Model Number 74121150

Device Problem Biocompatibility (2886)

Patient Problems Cyst(s) (1800); Osteolysis (2377); Metal Related Pathology (4530)

Event Date 09/27/2021

Event Type  Injury  

Event Description

It was reported that, after a primary bhr resurfacing construct had been implanted on the patient¿s right hip on (b)(6) 2007, the patient experienced elevated serum cobalt and chromium levels, osteolysis of the posterior femoral neck and extensive pseudotumor formation around the capsule and femoral neck.A revision surgery was performed on (b)(6) 2021 to treat this adverse event.During this procedure, the acetlr cup hap 58mm w/ imptr and the resurfacing femoral head 50mm were explanted and replaced with a thr prosthesis construct.Intraoperatively, there were cysts extending centrally to the floor of the acetabulum and anteriorly into the pubis with a large defect in the posterior wall.All of these were debrided to healthy bone.The patient was transferred to the recovery room in stable condition.

Manufacturer Narrative

Internal complaint reference: (b)(4).

Manufacturer Narrative

Sections d4 (expiration date) and h4 updated due to new information received.Sections g2 and h6 (health effect - clinical code) corrected.

Manufacturer Narrative

It was reported that the patient experienced elevated serum cobalt and chromium levels, osteolysis of the posterior femoral neck and extensive pseudotumor formation around the capsule and femoral neck.A revision surgery was performed on (b)(6)2021 to treat this adverse event.Intraoperatively, there were cysts extending centrally to the floor of the acetabulum and anteriorly into the pubis with a large defect in the posterior wall.The devices, used in treatment, were not returned for analysis.A review of the historical complaints data for the devices concerned was performed using batch numbers to evaluate patterns of repeated failures or defects over the lifetime of the product and using part numbers and the reported failure modes to evaluate patterns of repeated failures or defects in a timeframe prior 12 months as of the complaint aware date.One other complaint was identified involving the acetabular cup batch.No complaints involved the femoral head batch.Other similar complaints were identified for both part numbers and the reported failure mode.This will continue to be monitored.In the absence of the actual devices, the production records were reviewed for the devices reportedly involved in this incident.All released devices involved met manufacturing specifications upon release for distribution.Review of the product ifu found adequate warnings and precautions in relation to the alleged failure modes.A risk management review was performed.The alleged failure modes and associated risks have been anticipated within the risk file and the anticipated risk level is still adequate.A review of historic escalation actions related to the products and similar complaint events was performed.Following the review, no prior applicable escalation actions were identified.The clinical information provided, of gray-tinged joint fluid and soft tissue, pseudotumor, and osteolysis may be consistent with a reaction to metal debris.However, the source and the root cause cannot be determined with the available documentation.It cannot be concluded that the reported clinical findings are associated with the implant failure.Based on the available information we can confirm the reported complaint, however without further information our investigation remains inconclusive, and a definitive root cause cannot be determined.Specific factors known to contribute to the alleged fault are excessive physical activity levels, unreasonable stress on replacement system, excessive patient weight, trauma to the joint replacement, loosening of components may increase production of wear particles and accelerate damage to the bone.Should the devices or additional information be received, the complaint will be reopened.Based on this investigation, the need for corrective and preventative actions is not indicated.

• Brand Name: RESURFACING FEMORAL HEAD 50MM
• Type of Device: PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING
• Manufacturer (Section D): SMITH & NEPHEW ORTHOPAEDICS LTD; aurora house, spa park; leamington spa warwickshire CV31 3HL; UK CV31 3HL
• Manufacturer (Section G): SMITH & NEPHEW ORTHOPAEDICS LTD; aurora house, spa park; leamington spa warwickshire CV31 3HL; UK CV31 3HL
• Manufacturer Contact: holly topping ; 7000 west william cannon drive; austin, TX 78735 ; 5123913905
• MDR Report Key: 14466223
• MDR Text Key: 292351517
• Report Number: 3005975929-2022-00313
• Device Sequence Number: 1
• Product Code: NXT
• UDI-Device Identifier: 03596010502797
• UDI-Public: 03596010502797
• Combination Product (y/n): N
• Reporter Country Code: US
• PMA/PMN Number: P040033
• Number of Events Reported: 1
• Summary Report (Y/N): N
• Report Source: Manufacturer
• Source Type: Other,Company Representative
• Reporter Occupation: Other
• Type of Report: Initial,Followup,Followup
• Report Date: 08/11/2022

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Date FDA Received: 05/21/2022
• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: No
• Device Operator: Health Professional
• Device Expiration Date: 04/30/2012
• Device Model Number: 74121150
• Device Catalogue Number: 74121150
• Device Lot Number: 74332
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: No
• Date Manufacturer Received: 08/10/2022
• Was Device Evaluated by Manufacturer?: Device Not Returned to Manufacturer
• Date Device Manufactured: 04/24/2007
• Is the Device Single Use?: Yes
• Is This a Reprocessed and Reused Single-Use Device?: No
• Type of Device Usage: A
• Patient Sequence Number: 1
• Patient Outcome(s): Required Intervention
• Patient Age: 69 YR
• Patient Sex: Male